Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MASI
576
DELISTED
Masimo
MASI
| $40.8M | 0.04% |
274,000
-71,000
| -21% | -$9.74M |
|
|
CHU
577
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $40.8M | 0.04% |
3,739,030
+610,574
| +20% | +$7M |
|
|
CCF
578
DELISTED
Chase Corporation
CCF
| $40.7M | 0.04% |
378,400
+500
| +0.1% | +$49.5K |
|
579
Kimco Realty
KIM
$16.2B
| $40.6M | 0.04% |
2,197,701
-668,300
| -23% | -$12.1M |
|
|
CYBR
580
DELISTED
CyberArk
CYBR
| $40.5M | 0.04% |
316,600
-133,100
| -30% | -$16.8M |
|
|
EVRI
581
DELISTED
Everi Holdings
EVRI
| $40.3M | 0.04% |
3,378,700
+565,500
| +20% | +$6.14M |
|
582
Santander
BSBR
$43.1B
| $40.1M | 0.04% |
3,531,330
+740,196
| +27% | +$8.04M |
|
|
ONCE
583
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $39.9M | 0.04% |
+389,700
| New | +$42.1M |
|
584
Southside Bancshares
SBSI
$979M
| $39.9M | 0.04% |
1,232,110
-58,500
| -5% | -$1.98M |
|
585
Healthcare Realty
HR
$6.58B
| $39.8M | 0.04% |
1,451,672
-1,074,900
| -43% | -$30.3M |
|
586
Northwest Natural Holdings
NWN
$2.12B
| $39.8M | 0.04% |
572,100
-108,500
| -16% | -$7.34M |
|
|
CSFL
587
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $39.7M | 0.04% |
1,724,442
+117,205
| +7% | +$2.75M |
|
588
RingCentral
RNG
$5.25B
| $39.7M | 0.03% |
345,100
-93,600
| -21% | -$10.8M |
|
589
ATN International
ATNI
$478M
| $39.5M | 0.03% |
684,300
+35,700
| +6% | +$2.14M |
|
590
Forrester Research
FORR
$220M
| $39.5M | 0.03% |
839,018
+42,418
| +5% | +$2.04M |
|
591
Vanda Pharmaceuticals
VNDA
$314M
| $39.4M | 0.03% |
2,798,050
+233,300
| +9% | +$3.71M |
|
592
W&T Offshore
WTI
$555M
| $39.3M | 0.03% |
7,924,377
-8,723
| -0.1% | -$47K |
|
593
Park Hotels & Resorts
PK
$2.99B
| $39.3M | 0.03% |
1,425,400
+570,900
| +67% | +$17.1M |
|
|
CORR
594
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $39.2M | 0.03% |
988,000
+82,200
| +9% | +$3.2M |
|
595
Ally Financial
ALLY
$13.5B
| $39.2M | 0.03% |
1,263,800
+574,700
| +83% | +$17M |
|
596
West Pharmaceutical
WST
$24.8B
| $38.7M | 0.03% |
309,000
-111,600
| -27% | -$13.2M |
|
597
RE/MAX Holdings
RMAX
$263M
| $38.6M | 0.03% |
1,255,000
+81,100
| +7% | +$2.91M |
|
598
Bank of Hawaii
BOH
$3.13B
| $38.2M | 0.03% |
461,200
-9,500
| -2% | -$764K |
|
|
AUY
599
DELISTED
Yamana Gold, Inc.
AUY
| $38.2M | 0.03% |
15,152,290
-274,875
| -2% | -$605K |
|
600
Brookfield
BN
$110B
| $37.9M | 0.03% |
2,220,815
+1,969,410
| +783% | +$33.3M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.